TAMPA, Fla. (May 12, 2009) – Kforce Clinical Research Inc., a provider of clinical trial resourcing solutions and a division of Kforce Inc. (NASDAQ: KFRC), has won the 2008 Pfizer Development Operations’ “Strategic Supplier Excellence Award.” The annual award recognizes functional service providers that have demonstrated consistent performance in the areas of quality, service delivery and reliability, innovation and business processes and customer service.
“This recognition is the direct result of the efforts and accomplishments of our tremendously talented and dedicated team members,” said Randy Kehrmeyer, president of Kforce Clinical Research. “We are driven by a shared belief that we have an opportunity – and an obligation – to make a meaningful impact in the lives of our employees, clients and ultimately the countless patients in need of the medicines we are working together to develop.”
Kforce Clinical Research managed project deliverables for more than 200 Pfizer studies consistently throughout the year. Applying the principals of Lean Six Sigma, Kforce streamlined business processes across the U.S. and provided Pfizer with a more consultative view into project staffing and overall protocol management. Kforce also instituted a new business model for site selection that has improved study start-up time.
“Kforce has consistently demonstrated superior performance, adding high value to the U.S. clinical operations business,” said Mike Collins, vice president of clinical study operations at Pfizer. “In addition to exceeding expectations across all award categories, Kforce implemented strong business tools and processes that had meaningful impacts supporting our commitment for continuous improvement within Pfizer.”
Kforce Clinical Research www.kforce.com/clinicalresearch provides customized and flexible functional outsourcing solutions to the biopharmaceutical industry. It specializes in clinical monitoring, site and study management, drug safety, regulatory, clinical data management, data entry, clinical programming and biostatistics. Whereas other outsourcing providers either augment a company’s drug trial with people or handle all aspects of the trial, Kforce’s functional outsourcing model offers a flexible, tailored approach developed to mirror each company’s business model and address specific requirements of the drug trial itself.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.